» Articles » PMID: 33199722

TZM-gfp Cells: a Tractable Fluorescent Tool for Analysis of Rare and Early HIV-1 Infection

Overview
Journal Sci Rep
Specialty Science
Date 2020 Nov 17
PMID 33199722
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Here we describe TZM-gfp, a novel HIV-1 reporter cell derived from the same parental clone JC.53, used previously to generate the widely-utilized indicator cell line TZM-bl. We re-engineered JC.53 cells to express GFP under regulation of HIV Tat and Rev. We characterize the new reporter cell line to show that TZM-gfp cells are equally susceptible to HIV infection, exhibit minimal background signal, and can report HIV infection in rare cells from a bulk population of experimentally-infected human monocyte-derived macrophages. We demonstrate the utility and sensitivity of the cells in detection of even a single HIV-positive macrophage by fluorescence-assisted correlative electron microscopy, using the GFP signal to guide imaging of HIV virions in primary co-culture. Finally, we used TZM-gfp cells for viral capture during co-culture with human peripheral blood mononuclear cells, showing that TZM-gfp can support outgrowth and analyses of patient-derived primary HIV-1 isolates.

Citing Articles

Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques.

Hetrick B, Siddiqui S, Spear M, Guo J, Liang H, Fu Y Gene Ther. 2024; 32(1):16-24.

PMID: 39025983 PMC: 11785524. DOI: 10.1038/s41434-024-00467-9.


Inhibition of Infectious HIV-1 Production by Rerouting the Cellular Furin Inhibitor Serpin B8.

Petersen M, Lotke R, Hopfensperger K, Victoria S, Haussmann I, Burster T J Virol. 2023; 97(6):e0029423.

PMID: 37272794 PMC: 10308892. DOI: 10.1128/jvi.00294-23.


The CCR5 Gene Edited CD34CD90 Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy.

Karuppusamy K, Demosthenes J, Venkatesan V, Christopher A, Babu P, Azhagiri M Front Immunol. 2022; 13:792684.

PMID: 35359982 PMC: 8963924. DOI: 10.3389/fimmu.2022.792684.


The TZM-bl Reporter Cell Line Expresses Kynureninase That Can Neutralize 2F5-like Antibodies in the HIV-1 Neutralization Assay.

Morozov V, Lagaye S, Morozov A Int J Mol Sci. 2022; 23(2).

PMID: 35054825 PMC: 8775840. DOI: 10.3390/ijms23020641.

References
1.
Avalos C, Price S, Forsyth E, Pin J, Shirk E, Bullock B . Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2016; 90(12):5643-5656. PMC: 4886778. DOI: 10.1128/JVI.00290-16. View

2.
Metcalf Pate K, Blankson J . The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs. Retrovirology. 2017; 14(1):52. PMC: 5697021. DOI: 10.1186/s12977-017-0376-z. View

3.
Sarzotti-Kelsoe M, Bailer R, Turk E, Lin C, Bilska M, Greene K . Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. J Immunol Methods. 2013; 409:131-46. PMC: 4040342. DOI: 10.1016/j.jim.2013.11.022. View

4.
Sanyal A, Mailliard R, Rinaldo C, Ratner D, Ding M, Chen Y . Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4 T cells. Nat Med. 2017; 23(7):885-889. PMC: 5505781. DOI: 10.1038/nm.4347. View

5.
PLATT E, Wehrly K, Kuhmann S, Chesebro B, Kabat D . Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol. 1998; 72(4):2855-64. PMC: 109730. DOI: 10.1128/JVI.72.4.2855-2864.1998. View